Piccolo inhibitors represent a unique class of chemical compounds that target piccolo, a large presynaptic protein primarily located at the active zones of synapses. Piccolo is part of the Bassoon-Piccolo complex and plays a crucial role in the assembly and maintenance of synaptic structures, as well as in the regulation of neurotransmitter release. The structure of piccolo includes multiple protein domains, such as PDZ domains, which facilitate interactions with various other proteins and cellular components, thus contributing to its functional diversity within synapses. By inhibiting piccolo, these compounds can disrupt the normal processes of synaptic transmission and plasticity, providing valuable insights into neuronal communication and function.
The development of piccolo inhibitors has opened new avenues for research into synaptic mechanisms and their implications for neurobiology. By studying the effects of these inhibitors, scientists can better understand how piccolo influences synaptic architecture, vesicle trafficking, and the dynamics of neurotransmitter release. This knowledge is essential for elucidating the molecular underpinnings of synaptic behavior and can aid in exploring potential interventions for synaptic dysfunctions. Furthermore, as piccolo is involved in various signaling pathways, inhibitors may provide a means to dissect complex cellular processes that contribute to the overall physiology of neurons. In this way, piccolo inhibitors serve as important tools for advancing our understanding of synaptic biology and the intricate networks that govern neural communication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 is a V-ATPase inhibitor that can disrupt the proton gradient in synaptic vesicles, potentially influencing piccolo's role in vesicle trafficking. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Latrunculin A disrupts actin polymerization, which can affect the actin cytoskeleton at the active zone and potentially piccolo's role in synaptic architecture. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $229.00 | 33 | |
Phalloidin stabilizes actin filaments, which can impact piccolo's association with the actin cytoskeleton at the presynaptic terminal. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Colchicine disrupts microtubule polymerization, which can affect trafficking to the presynaptic terminal and indirectly impact piccolo function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Nocodazole is another microtubule destabilizer, which can affect axonal transport and potentially piccolo's role in synaptic vesicle supply. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $219.00 $765.00 | 19 | |
Ryanodine disrupts calcium release from the endoplasmic reticulum, which can affect calcium dynamics in the neuron and potentially piccolo's role in vesicle release. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $133.00 | 7 | |
W-7 is a calmodulin antagonist that can affect calcium signaling, potentially impacting piccolo's role in calcium-dependent processes in neurotransmission. | ||||||